Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$36.06 - $117.21 $17.7 Million - $57.5 Million
490,500 Added 793.69%
552,300 $60.8 Million
Q3 2022

Nov 14, 2022

BUY
$28.17 - $59.01 $619,740 - $1.3 Million
22,000 Added 55.28%
61,800 $3.65 Million
Q2 2022

Aug 15, 2022

BUY
$22.39 - $38.94 $891,122 - $1.55 Million
39,800 New
39,800 $1.12 Million

Others Institutions Holding RXDX

About Prometheus Biosciences, Inc.


  • Ticker RXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,904,100
  • Description
  • Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...
More about RXDX
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.